Subject: Smallcap Discoveries: Aequus Pharmaceuticals (TSX.V: AQS) Update with CEO Doug Janzen

Aequus Pharmaceuticals (TSX.V: AQS) Update with CEO Doug Janzen
ABOUT AEQUUS PHARMACEUTICALS INC.

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial products in ophthalmology and transplant. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas. For further information, please visit www.aequuspharma.ca.

Video Interview:
After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist
86 East 23rd Ave, v5v 1w9, Vancouver, Canada
You may unsubscribe or change your contact details at any time.